Trondheim, Norway

Berit Johansen

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Oslo, NO (2018 - 2020)
  • Trondheim, NO (2010 - 2023)

Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: The Innovative Journey of Berit Johansen: Pioneering Advancements in Anti-Inflammatory Compounds

Introduction: Berit Johansen, a notable inventor based in Trondheim, Norway, has made significant contributions to the field of medicinal chemistry through his innovative research and development. With a prolific portfolio of 19 patents, he stands as a key figure in the advancement of pharmaceutical compounds that aim to improve health outcomes and combat proliferative diseases.

Latest Patents: Among his most recent inventions are groundbreaking patents focused on anti-inflammatory and antitumor properties. One notable patent features a compound of formula (I) characterized by specific substitutions that enhance its therapeutic efficacy. These compounds include 2-oxothiazoles and 2-oxothiophenes, showcasing the intricate chemical designs aimed at targeting various pathways in inflammatory and tumorigenic processes. Another recent patent outlines a combination therapy for proliferative diseases, emphasizing the synergy between multiple compounds to maximize therapeutic potential. These inventions are essential as they offer new avenues for treatment and reflect the cutting-edge work being done in pharmaceutical research.

Career Highlights: Berit Johansen serves as a key scientist at Avexxin AS, where he plays a pivotal role in advancing the company’s innovative pharmaceutical projects. Throughout his career, he has secured intellectual property rights for his inventions, thereby contributing to the broader field of medical science and establishing a reputation as a leading inventor in his area of expertise.

Collaborations: Johansen collaborates with esteemed colleagues, including George Kokotos and Inger-Reidun Aukrust. Their joint efforts enhance the research capabilities at Avexxin AS, facilitating groundbreaking studies that explore the therapeutic potential of new compounds. Through these collaborations, they aim to push the boundaries of current scientific understanding.

Conclusion: Berit Johansen’s contributions to the field of medicinal chemistry are profound and impactful. His extensive patent portfolio and innovative spirit not only reflect his dedication to overcoming health challenges but also inspire future generations of inventors and scientists. With ongoing research and development, Johansen continues to pave the way for advancements in therapeutics, reinforcing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…